// App-Quantinova.ai

226 : Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population

Researchers

Presenter

  • Maxime Dougados

Principal Investigators

  • Bruno J Fautrel

  • Mart A F J Van De Laar

  • Bruce Kirkham

  • Rieke Alten

  • Regina Cseuz

  • Josef S Smolen

  • Juan Sanchez-Burson

  • Paul Bird

  • Morton Scheinberg

  • Filip Van Den Bosch

  • Jane Barry

  • Frederick Durand

  • Baojin Zhu

  • Francesco De Leonardis

  • Peter C Taylor

Medical Centers

  • Department of Dermatology, Bichat Hospital, Paris, France

  • Hôpital Pitié-Salpêtrière, University Pierre et Marie Curie, Paris, FRANCE

  • Arthritis Center, University of Twente, Twente, NETHERLANDS

  • Schlosspark Klinik, University Medicine Berlin, Berlin, GERMANY

  • Rheumatology, Revita Clinic, Budapest, HUNGARY

  • Rheumatology, Medical University Vienna, Vienna, -

  • Rheumatology, Hospital Infantaluisa of Sevilla, Sevilla, SPAIN

  • Rheumatology, University of New South Wales, Sydney, AUSTRALIA

  • Reumatologia, Hospital Israelita Albert Einstein, Sao Paulo, BRAZIL

  • Rheumatology, UZ Gent, Gent, BELGIUM

  • Rheumatology, Eli Lilly and Company, Basingstoke, Hampshire, UNITED KINGDOM

  • Rhumatologie, Lilly France, Neuilly-sur-Seine, FRANCE

  • Medical Oncology, Eli Lilly and Company, Indianapolis, IN, USA

  • Rheumatology, Eli Lilly and Company, Geneva, SWITZERLAND

  • Nuffield Dept. of Orthopaedics, Rheumatology and Musculoskeletal, Sciences, Kennedy Institute of Rheumatology, University of Oxford,, Oxford, United Kingdom

Locations

  • France

  • Netherlands

  • United Kingdom

  • Germany

  • Hungary

  • Austria

  • Spain

  • Australia

  • Brazil

  • Belgium

  • United States

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Baricitinib

  • BARI

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT01710358

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved